Jim Engelhart

Jim Engelhart is a seasoned biopharmaceutical executive currently serving as Chief Financial Officer at Biohaven Pharmaceutical Holding Company, Ltd since May 2016. Engelhart possesses extensive leadership experience in corporate finance, commercial launches, international operations, mergers and acquisitions, and corporate structure strategy, along with a strong foundation in accounting and control. Prior roles include Executive Director Finance for the Americas at Alexion Pharmaceuticals, Finance Director for various divisions at Energizer, and Finance Director at Bristol-Myers Squibb, among others. Engelhart's career began as a Senior Financial Auditor at Coopers and Lybrand after earning a Bachelor's Degree in Accounting from Villanova University.